• Greenhouse Conference

    first_imgSoutheast Greenhouse Conference June 16-19ÿThe Southeast Greenhouse Conference and Trade Show will be at the Palmetto ExpoCenter inÿ Greenville, S.C., June 16-19. Grower associations and Extension Servicefaculty in seven Southern states sponsor the event. ÿIn a three-day educational program, nationally renowned speakers will give growers thecompetitive edge to increase their market share.The program will focus on greenhouse management and garden center marketing. It’sdesignedÿ to address the special needs of Southern growers. Sessions will featureperennials, annuals, water gardens and selling on the Web. “Getting Started in the Greenhouse Business, Part 2” will pick up where lastyear’s popularÿ workshop left off. It’s a daylong, information-packed program on thebusiness basics of running a greenhouse.ÿThe trade show boasts more greenhouse industry suppliers than you can find in oneplace anywhere else in the Southeast. It will have more than 350 booths. For those who’dlike to start their own retail outlet, it will feature a demonstration garden center.ÿFor the seventh year, the event will include a golf outing. This year’s tournament willbe at the Verdae Greens Golf Club in Greenville. To learn more about the event, or toregister on-line, visit the show’s Web site at .Or call 1-877-927-2775 (toll free).last_img read more

  • Uruguayan President Concerned Over Arms Race In Latin America

    first_imgBy Dialogo September 15, 2009 Uruguayan President Tabare Vazquez, and Secretary of State, Hillary Clinton, expressed their concern about an arms race in Latin America, announced after the massive purchases by Venezuela. “The race is already there, it’s a reality,” Vazquez said in a press conference after meeting with Clinton at the State Department. “Not only is our country worried” about the arms race, but it also opposes it because it diverts resources in countries that suffer great poverty, Vazquez said. “It’s a fact that the countries (in the region) are buying weapons,” added the Uruguayan president. “Hopefully we can see a change of attitude in Venezuela,” Clinton said for her part. The Secretary of State insisted that her government has already expressed its “concern for a number of arms purchases from Venezuela,” which, she said, “surpasses the rest of the region.” “We urge Venezuela to be transparent, clear about the purpose of these arms purchases,” Clinton said. Venezuela obtained a loan of $2 billion dollars for the purchase of arms from Russia, stated by President Hugo Chávez, who stressed the acquisition of 92 T72 tanks and an unknown number of anti-aircraft systems to the country, following an extensive international tour . One of the pitfalls, warned the head of U.S. diplomacy, is the possible diversion of these weapons to armed groups or terrorists in the region.last_img read more

  • Ecuador Condemns Killings In Mexico And Mobilizes Diplomats

    first_img The foreign minister of Ecuador, Ricardo Patiño, condemned the killings of seventy-two people in northeastern Mexico, thought to include a number of Ecuadoreans, and announced the mobilization of Ecuador’s diplomatic personnel in that country in order to support the investigations. “This is very serious and lamentable, but the embassy and the consulates were immediately mobilized,” the minister said following a meeting with his Mexican counterpart, Patricia Espinosa, in Quito. Patiño indicated that he was informed of the massacre by the Mexican foreign minister, who told him that the discovery of the corpses on a ranch in Tamaulipas was the result of the testimony of an Ecuadorean survivor who went to the authorities in search of aid. “Foreign Minister Espinosa informed me about an occurrence (…) in which seventy-two people died, counting Central Americans and South Americans. We don’t know how many were Ecuadoreans; I hope not many,” the diplomat said. Patiño likewise said that Espinosa told him that “she is immediately going to make available the Mexican government’s assistance” in identifying the bodies. Mexican military personnel found seventy-two corpses Tuesday on a ranch in the Mexican state of Tamaulipas (in the northeastern part of the country); according to preliminary official reports, the dead are thought to be immigrants from El Salvador, Honduras, Ecuador, and Brazil. By Dialogo August 30, 2010last_img read more

  • Lockheed Martin invites students to facility, fosters interest in STEM

    first_imgOWEGO (WBNG) — Lockheed Martin celebrated engineering week Friday. About 160 8th grade students from 14 Broome County School attended the event at Lockheed’s Owego facility. Students participated in STEM activities, tours and employee interaction all part of the experience. “It’s a great learning opportunity,” said Engineering Program Manager Mary Driver. “I’ve watched them start with the ‘I have no idea what I’m doing’ to the very end where you see the ‘aha’s’ and things start to click.”center_img The company invited students to learn about STEM fields. They learned about science opportunities, technology engineering and mathematics in the hope of shaping future career paths.last_img

  • More military personnel to get anthrax and smallpox shots

    first_img Jun 30 statement by William Winkenwerder, Jr. Some military personnel have refused anthrax shots because of concerns about side effects. The program was suspended for about 2 weeks last December and January because of a federal court order in a lawsuit brought by six service members seeking to stop the vaccinations. DoD smallpox vaccination program site DoD recently evaluated the vaccination program and risk of biological attack and concluded that the threat continues, Winkenwerder said in a prepared statement. “In light of our successful implementation of these programs and the increased quantities of vaccine, we will include additional forces in the vaccination programs,” he said. Jun 28 memo from Deputy Secretary of Defense Paul Wolfowitz DoD Anthrax Vaccine Immunization Program site A memo from Deputy Defense Secretary Paul Wolfowitz on the vaccination programs was posted on a DoD Web site. It calls for vaccination of uniformed personnel assigned to Korea or likely to be deployed there in a crisis, plus “emergency essential” civilian DoD workers and employees of military contractors handling essential services in Korea. The memo also calls for voluntary vaccinations for family members of military personnel in Korea, other DoD civilian employees and their families there, and “non-essential” contractor personnel there. For the Central Command Area, the memo calls for immunization of all uniformed personnel, emergency-essential civilian workers, and contractor employees handling essential services. DoD officials ordered vaccinations for uniformed personnel and some civilian and contract workers serving in South Korea. They also ordered an expansion of vaccinations in the Central Command Area, consisting primarily of the Middle East, to include all uniformed personnel. Some troops in the Middle East have already had the shots.center_img Jul 1, 2004 (CIDRAP News) – More US troops and civilian defense workers serving overseas will be getting smallpox and anthrax vaccinations in coming months, the US Department of Defense (DoD) announced yesterday. Winkenwerder said in his statement, “Refusals [of anthrax vaccination] among service members leading to separations from the service have been extremely rare since 2002, only four per 100,000 persons vaccinated.” William Winkenwerder, Jr., assistant secretary of defense for health affairs, cited an increase in vaccine supplies as the reason for expanding the program; he did not mention any increase in the threat of biological warfare. More than 627,000 service members have received smallpox shots since that immunization program began in December 2002, according to DoD reports. See also: The DoD announcement did not include any estimate of how many additional personnel will be vaccinated in the expanded program. DoD reports that about 1.1 million people have received anthrax shots since the anthrax immunization program began in March 1998. The program was sharply reduced in 2000 because of a shortage of vaccine related to problems with the manufacturing plant, but it was later increased again. Since June 2002, about 750,000 service members have received more than 2.2 million doses of anthrax vaccine, DoD officials said. Vaccination involves six shots over 18 months, plus annual boosters afterward.last_img read more

  • A scientific scramble for space

    first_imgTo access this article REGISTER NOWWould you like print copies, app and digital replica access too? SUBSCRIBE for as little as £5 per week. Would you like to read more?Register for free to finish this article.Sign up now for the following benefits:Four FREE articles of your choice per monthBreaking news, comment and analysis from industry experts as it happensChoose from our portfolio of email newsletterslast_img

  • A tale of two developers

    first_imgTo access this article REGISTER NOWWould you like print copies, app and digital replica access too? SUBSCRIBE for as little as £5 per week. Would you like to read more?Register for free to finish this article.Sign up now for the following benefits:Four FREE articles of your choice per monthBreaking news, comment and analysis from industry experts as it happensChoose from our portfolio of email newsletterslast_img

  • China’s CanSino defends coronavirus vaccine candidate after experts cast doubt

    first_imgIt is unscientific to compare the antibody levels generated by different vaccine candidates so far, because varied testing methods could distort results, Zhu said.AstraZeneca Plc on Tuesday said it paused a late-stage trial of one of its leading experimental viral vector-based vaccine, which uses a technology similar to CanSino’s, after an unexplained illness in a study participant.The hiccup does not mean all viral-vector based experimental vaccines are risky, Zhu said, adding that it was not rare for clinical trials to be paused.CanSino’s shares were up 6% at HK$181.50 ($23.42) on Wednesday afternoon in Hong Kong. He said there were instances in which vaccines created using methods doubted by experts had obtained regulatory approvals after clinical trials proved they worked.No evidence showed that existing antibodies against the common cold could have a major adverse impact on Ad5-nCoV’s ability to trigger antibodies against the novel coronavirus, Zhu said, citing results from 128 participants tested with a lower dose of the vaccine candidate in a mid-stage trial.Ad5-nCoV, still in final-stage trials, has been approved for use in the Chinese military.Vaccine companies normally have to collect data in large-scale, late-stage trials to obtain regulatory approval for mass use. China’s CanSino Biologics Inc said on Wednesday that expert opinion on its high-profile coronavirus vaccine candidate should not be followed “blindly” without sufficient clinical trial data.Scientists outside the company have expressed concern that the effectiveness of CanSino’s candidate Ad5-nCoV, which is based on a common cold virus to which many people have been exposed, could be limited. They said existing antibodies against the common cold virus might undermine Ad5-nCoV.”Vaccine development is a practice-based science, and we should not blindly follow experts,” Zhu Tao, chief scientific officer, said during an investor conference.center_img Topics :last_img read more

  • Building supplies scheme seeking new provider

    first_imgThe €333m Dutch Pensioenfonds Rockwool is considering its options for switching to new provider, after the employer and the unions indicated that they wanted to make a change this year.In a newsletter, the scheme – which serves current and former employees of building supplies company Rockwool – said the social partners’ involvement had accelerated its exploration of options, a process that had already started at the request of regulator De Nederlandsche Bank (DNB).The scheme’s supervisory board andt accountability body had also both urged the main board to come up with a vision for its future.The pension fund and the social partners are considering transferring future accrual to a new provider, and moving existing pension rights and legacy benefits to another party. In both scenarios, the sponsor would terminate its contract with the pension fund.The Pensioenfonds Rockwool said it was exploring the possibilities of joining another pension fund for future accrual and placing its other pension rights with an insurer or a general pension fund (APF).It added that it was also considering the option of moving its pensions to a provider in Belgium.However, the Rockwool scheme said its choices would be limited because of its low funding position of 100.4% at November-end.The social partners and the pension fund said they wanted to involve members in their search for a solution through a survey.The Pensioenfonds Rockwool has almost 1,200 active participants and reported administration costs of €366 per participant for 2017.During 2017, asset management costs rose from 33 to 69 basis points, which the scheme in part attributed to a switch from NN IP to Northern Trust, changing its actively managed equity mandate into a passively managed one. NN IP, however, stayed on as fiduciary manager for the pension fund.The Rockwool scheme has a 30% allocation to equity, with the remainder of its portfolio invested in fixed income.last_img read more

  • US cancer institute signs agreement to import vaccine developed in Cuba

    first_img Share BusinessHealthInternationalLifestylePrint US cancer institute signs agreement to import vaccine developed in Cuba by: Caribbean Media Corporation – April 23, 2015 Tweet HAVANA, Cuba (CMC) – Cuba’s Centre of Molecular Immunology and New York’s Roswell Park Cancer Institute, have signed an agreement to export to the United States, a therapeutic vaccine against lung cancer developed here. “The agreement will allow us to limit ourselves to clinical trials of the vaccine when we get to New York,” said Candace Johnson, the director of the Roswell Park Cancer Institute.Johnson was part of a trade delegation from New York, led by governor, Andrew Cuomo, to explore business options here, in addition to promoting exchanges in education and research.“We are excited to bring the vaccine to the US and treating patients. This would not have been possible without this trade mission, which facilitated the initialling of the agreement face to face, “said JohnsonThe vaccine against lung cancer was created in Cuba in 2011 after 15 years of research with patent rights worldwide.The vaccine – Cimivax, reportedly doubles as a treatment for lung cancer.The vaccine is registered in Cuba and Peru, although countries like Brazil, Argentina and Colombia are in the process for registration, and others such as the UK and Australia have conducted clinical trials. Sharecenter_img 203 Views   no discussions Sharing is caring! Sharelast_img read more